Introduction
============

*Klebsiella pneumoniae* is one of the most common bacterial pathogens isolated from clinical infections. Certain sequence and capsular types (e.g., ST23:K1) of the organism display the hypermucoviscous phenotype and carry a number of critical virulence factors such as regulators of mucoid phenotype (*rmpA, rmpA2*), aerobactin (*iucABCD, iutA*), colibactin (*clbA-R*), salmochelin (*iroN, iroBCD*), and yersiniabactin (*irp2, ybtAEPQTUX*) ([@B4]; [@B14]). These hypervirulent *K. pneumoniae* (hvKP) are a particular threat for human health as they are able to cause severe infections in apparently healthy persons with high mortality ([@B30]). hvKP is commonly susceptible to many antimicrobial agents including carbapenems and colistin ([@B30]; [@B14]). However, some carbapenem-resistant hvKP strains have been found in China and belong to the widely distributed sequence type 11 (ST11) ([@B37]; [@B12]) and several other sequence types, e.g., ST25 and ST65 ([@B35]). A recent study ([@B12]) has revealed that an ST11 carbapenem-resistant *K. pneumoniae* acquired a pLVPK-like virulence plasmid and therefore became hypervirulent. The combination of carbapenem resistance and hypervirulence significantly compromises options of antimicrobial agents for treating the life-threatening infections caused by these strains and therefore represents a major urgent challenge for clinical treatment, infection control and public health ([@B6]). Colistin is the last resort agent against carbapenem-resistant *K. pneumoniae* but colistin-resistant *K. pneumoniae* has also emerged worldwide ([@B22]). The combination of colistin resistance and hypervirulence will represent another major urgent challenge for human health. Here we report the isolation and characterization of five colistin-resistant hvKP clinical strains from different clonal backgrounds.

Materials and Methods {#s1}
=====================

Strains and *in vitro* Susceptibility
-------------------------------------

Non-duplicated *Klebsiella* strains that were recovered from the blood of patients at West China Hospital, Sichuan University between December 2015 and July 2016 were collected. Initial species identification was performed using Vitek II (bioMérieux, Marcy-l'Étoile, France) and MALDI-TOF (Bruker, Billerica, MA, United States). The study has been approved by the Ethical Committee of West China Hospital with inform consent being waived. *In vitro* susceptibility tests of amikacin, ceftriaxone, ciprofloxacin, gentamicin, imipenem, piperacillin-tazobactam, sulfamethoxazole-trimethoprim, and tigecycline were performed using Vitek II. MICs of colistin were determined using the broth microdilution method of the Clinical and Laboratory Standards Institute (CLSI) ([@B8]) and breakpoints of colistin defined by EUCAST^[1](#fn01){ref-type="fn"}^ were applied.

String Tests
------------

Colonies of the strains were stretched by an inoculation loop in the string test as described previously ([@B30]). The strains that formed viscous strings \> 5 mm in length were considered hypermucoviscous.

Whole Genomic Sequencing and Analysis
-------------------------------------

The strains were subjected to whole genomic sequencing using the HiSeq X10 Sequencer (Illumina, San Diego, CA, United States) with the 150-bp paired-end protocol and approximately 300 × coverage. Raw reads were processed via adapter-trimming (Illumina TruSeq DNA adapter), end-cropping (10-bp from both ends) and quality-filtering (lower than Q20) using Trimmomatic ([@B3]). Draft genomes were then assembled using Unicycler ([@B33]) in conservative mode with other settings remaining as default, and were annotated using Prokka ([@B28]). Species identification was further established by the pair-wise average nucleotide identity (ANI) between the isolates and type strains of *Klebsiella* species using the JSpecies program based on BLAST ([@B27]).

Sequence types of these strains were determined using the assembled contigs to query the multi-locus sequence typing database available at <http://bigsdb.pasteur.fr/klebsiella/klebsiella.html>, while the capsular typing was performed for *K. pneumoniae* strains using Kaptive ^[2](#fn02){ref-type="fn"}^. Antimicrobial resistance genes were predicted using ResFinder at the Center for Genomic Epidemiology.^[3](#fn03){ref-type="fn"}^ Small insertions and deletions, as well as high quality SNPs were identified by mapping reads against the draft genome of KP925 using snippy v4.0^[4](#fn04){ref-type="fn"}^ with default settings. Core SNPs were then used as the input for phylogenetic tree inference using RAxML ([@B31]) with a 1,000-bootstrap test. Virulence genes were identified using the database available at <http://bigsdb.pasteur.fr/klebsiella/klebsiella.html>. The well-studied 208,166-bp virulence plasmid pLVPK (IncHI1/IncFIB; GenBank accession no. AY378100) possesses *rmpA, rmpA2, iucABCD, iutA*, and *iroBCDN* and was selected as the reference to align contigs of the five strains in this study using BRIG ([@B1]).

### Nucleotide Sequence Accession Numbers

Draft whole-genome sequences of the five strains have been deposited into GenBank under the accession no. [NWCC00000000](NWCC00000000) (KP209), [NWCN00000000](NWCN00000000) (KP775), [NWDO00000000](NWDO00000000) (KP543), [NWEN00000000](NWEN00000000) (KP925), and [NWEQ00000000](NWEQ00000000) (KP767).

Cloning of *pmrB* Encoding a P344L Substitution
-----------------------------------------------

Two strains, KP925 and KP209, had no known chromosomal or plasmid-borne mechanisms mediating colistin resistance. However, their *pmrB* genes, which encode PmrB, part of the PmrAB two-component system, have a C1031T mutation encoding a P344L substitution. Whether the P344L substitution of PmrB could mediate colistin resistance has not been studied before. We therefore cloned the *pmrB* gene encoding the P344L substitution. The 1098*-*bp *pmrB* gene was amplified with self-designed primers XhoI_pmrAB_F (CCG[CTCGAG]{.ul}CGGTCATTACAGCCTGATCGTGCTGGATCTCG; the restriction site is underlined) and EcoRI_pmrAB_R (CCG[GAATTC]{.ul}CGGTCGTCCTGCTTGCCAGATAACAAACATTT) from strain KP925. The wild-type *pmrB* gene (without encoding the P344L substitution) and its promoter sequence was also amplified using the same primers from a colistin-susceptible *K. pneumoniae* strain, KP9G2, for control. Both PCR amplicons and the vector pBC SK (Stratagene, La Jolla, CA, United States) were digested using *Xho*I and *EcoR*I (NEB, Ipswich, MA, United States) and were ligated using T4 ligase (NEB) to construct pBC SK-*pmrB*^wild^ (containing *pmrB* from KP9G2) and pBC SK-*pmrB*^P344L^ (containing *pmrB* encoding the P344L substitution). pBC SK-*pmrB*^wild^ and pBC SK-*pmrB*^P344L^ were transformed into KP9G2, KP925, and KP209 by electroporation. Transformants were selected on agar plates containing 35 μg/ml chloramphenicol and *pmrB* sequences on the clonal vector in transformants were obtained using PCR with primers (M13 -20 and M13 reverse primers; Stratagene) binding to pBC SK and subsequent Sanger sequencing. To verify the expression of *pmrB*^wild^ or *pmrB*^P344L^, RNA was extracted from the transformants using the RNAprep pure cell/bacteria kit (Tiangen, Beijing, China) and cDNA was obtained using the Primescript RT reagent kit (Takara, Dalian, China), which was then used as the template for real-time PCR (RT-PCR). RT-PCR was performed using LightCycler 96 (Roche, Mannheim, Germany) with a primer (AAAAGCTGGAGCTCCACCG) binding to the pBC SK vector and another primer (GCGGCCTTTTTTCTTCTCAA) binding to *pmrB*. The 30S ribosomal subunit protein S12-encoding *rpsL* gene was used as a control for RT-PCR with the pair of primers rpsL13_F and rpsL14_F ([@B5]). MICs of colistin against transformants were determined using broth microdilution of CLSI ([@B8]).

Virulence Assay
---------------

The virulence of the strains was assessed using wax moth (*Galleria mellonella*) larvae weighing 250 to 350 mg (Tianjin Huiyude Biotech Company, Tianjin, China). Overnight cultures of *K. pneumoniae* strains were washed with phosphate-buffered saline (PBS) and further adjusted with PBS to concentrations of 1 × 10^4^ CFU/ml, 1 × 10^5^ CFU/ml, 1 × 10^6^ CFU/ml, 1 × 10^7^ CFU/ml. Sixteen larvae were injected with 10 μl of inoculum using a 25-μl Hamilton syringe into hemocoel via the last left proleg ([@B23]) and were then incubated at 37°C in plastic containers. The number of live larvae was counted every 12 h for 3 days. Two *bla*~KPC-2~-carrying carbapenem-resistant *K. pneumoniae* clinical isolates of ST11, KP10, and KP13F4, both of which had no *rmpA* and *rmpA2* genes, were used as the control. All experiments were performed in triplicate.

Results
=======

Among 112 *Klebsiella* strains collected from blood during the study period, five *K. pneumoniae* strains (Table [1](#T1){ref-type="table"}) were found to be colistin resistant (MIC, 4 to 16 μg/ml; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}) and hypervirulent (see below) and were therefore included in this study. The five *K. pneumoniae* strains were recovered from five different male patients with liver abscess, peritonitis or pancreatic cancer. There was no obvious epidemiological link among the five patients, as the hospitalization of the patients did not overlap. Three of the five strains were community acquired (as determined by days between admission and infection), all of which were associated with liver abscess, while the remaining two were hospital acquired and were not associated with liver abscess (Table [1](#T1){ref-type="table"}). Three of the five strains were hypermucoviscous. Two hypermucoviscous strains belonged to ST23:K1 (Table [1](#T1){ref-type="table"}), the best-known hypervirulent phylogenetic group of *K. pneumoniae* commonly associated with community-acquired pyogenic liver abscess ([@B4]). There were 286 SNPs between the two ST23:K1 strains, suggesting that they did not share a common transmission event. Another hypermucoviscous strain was identified as ST700:K1 (Table [1](#T1){ref-type="table"}). The remaining two strains formed mucoid strings \< 5 mm though they were mucoid on agar plates (Table [2](#T2){ref-type="table"}) and belonged to ST660:K16 and ST412:K57, respectively (Table [1](#T1){ref-type="table"}). A phylogenetic tree was inferred for the five strains (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}).

###### 

Characteristics of patients with bloodstream infection due to colistin-resistant hvKP.

  Strain   Acquisition^1^   Patient   Age   Sex    Major diseases                         Date^2^   Antimicrobial treatment   Outcome
  -------- ---------------- --------- ----- ------ -------------------------------------- --------- ------------------------- -----------
  KP767    Hospital         1         51    Male   Liver cirrhosis, primary peritonitis   2015-12   Piperacillin-tazobactam   Recovered
  KP925    Community        2         68    Male   Liver abscess                          2016-05   Panipenem                 Recovered
  KP543    Community        3         52    Male   Liver abscess                          2017-03   Imipenem plus aztreonam   Recovered
  KP775    Community        4         72    Male   Liver abscess                          2017-04   Imipenem                  Recovered
  KP209    Hospital         5         59    Male   Pancreatic cancer                      2017-06   Imipenem                  Death

1

The strain considered as community acquired if it was recovered from a sample collected within 48 h of hospitalization. Otherwise, the strain was considered hospital acquired.

2

Date refers to when the blood culture that grew colistin-resistant hvKP was collected

.

###### 

Characteristics of colistin-resistant hvKP.

  Strain   ST (allele no.^1^)        Capsular type   Hypermucoviscous   Colistin MIC   Colistin resistant mechanism   Antimicrobial resistance genes                                                                                                                                                   Virulence factors
  -------- ------------------------- --------------- ------------------ -------------- ------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  KP767    660 (2-1-2-1-4-1-25)      K16             \-                 4              PhoQ D150G                     *bla*~SHV\ -1~, *fosA, oqxA, oqxB*                                                                                                                                               *fyuA, iroBCDN, irp2, iucABCD, iutA, kfuAB, mrkABCDFHIJ, rmpA, rmpA2, ybtAEPQTUX*
  KP925    23 (2-1-1-1-9-4-12)       K1              \-                 8              Undefined^2^                   *bla*~SHV\ -36~, *fosA, oqxA, oqxB*                                                                                                                                              *allABCDRS, arcC, clbBK, fdrA, fyuA, gcl, glxKR, hyi, iroBCDN, irp1, irp2, iucABCD, iutA, kfuABC, KP1, mceABCDEGHIJ, mrkABCDFHIJ, rmpA, rmpA2, ybbWY, ybtAEPQTUX, ylbEF*
  KP543    412 (2-1-2-1-9-1-112)     K57             \+                 8              PhoQ D150G                     *bla*~SHV\ -11~, *fosA, oqxA, oqxB*,                                                                                                                                             *iroBCD, mrkABHI, rmpA, rmpA2*
  KP775    700 (10-1-17-37-12-1-9)   K1              \+                 16             *mcr-1* PhoQ D150G             *aph(4)-Ia, aac(3)-IVa, aph(3')-Ia, aadA1, aadA2, bla*~SHV\ -1~, *bla*~CTX-M-14~, *cmlA1, dfrA1, dfrA12, fosA, fosA, floR, mcr-1, oqxA, oqxB, qnrS1, sul1, sul2, sul3, tet(A)*   *fyuA, iroBCDN, irp2, iucABCD, iutA, rmpA, ybtAEPQTUX*
  KP209    23 (2-1-1-1-9-4-12)       K1              \+                 8              Undefined^2^                   *bla*~SHV\ -36~, *oqxA, oqxB*                                                                                                                                                    *allABCDRS, arcC, clbBK, fdrA, fyuA, gcl, glxKR, hyi, iroBCDN, irp1, irp2, iucABCD, iutA, kfuABC, KP1, mceABCDEGHIJ, mrkABCDFHIJ, rmpA, rmpA2, ybbWY, ybtAEPQTUX, ylbEF*

1

Allele order is gapA-infB-mdh-pgi-phoE-rpoB-tonB.

2

The two strains did not have any known plasmid-borne colistin-resistance genes (mcr-1 to -5) and any chromosomal mutations (e.g., mutations/insertions in PhoP-Q, PmrA-B, and MgrB) that are known to confer colistin resistance

.

All five strains carried *rmpA* and the salmochelin-encoding *iro* cluster plus various combinations of other hypervirulence-associated genes (Table [2](#T2){ref-type="table"}). Neither truncations nor stop codons were present within the open reading frames of these genes. The above virulence genes could be plasmid-borne ([@B4]; [@B14]). Three strains aligned to almost all parts of pLVPK including the region in which the *rmpA, rmpA2, iucABCD, iutA*, and *iroBCDN* genes were located, while the remaining two strains (KP543 and KP775) aligned to most parts of pLVPK except the 16-kb region containing *iucABCD/iutA* or *rmpA2*, respectively (Figure [1](#F1){ref-type="fig"}).

![Alignment of the virulence genes-carrying plasmid pLVPK and contigs belonged to the colistin-resistant hypervirulent strains. The alignment was performed using BRIG by aligning the draft genome sequences to pLVPK (GenBank accession no. AY378100). The locations of virulence genes *rmpA, rmpA2, iucABCD, iutA*, and *iroBCDN* are indicated.](fmicb-09-02568-g001){#F1}

The 80% lethal dose at 48h of strain KP767, KP925, KP543, KP775, and KP209 against *G. mellonella* was 1 × 10^4^, 1 × 10^4^, 1 × 10^5^, 1 × 10^6^, and 1 × 10^6^ CFU/ml, respectively. Using a bacterial inoculum of 1 × 10^6^ CFU/ml, survival of *G. mellonella* at 72 h after infection was 25% with strain KP209 (hypermucoviscous, ST23:K1) and was 0% with the remaining four colistin-resistant hvKP strains including two hypermucoviscous and two non-hypermucoviscous strains, while survival was 62.5 and 93.8% with the control strains KP10 and KP13F4, respectively (Figure [2](#F2){ref-type="fig"} and Supplementary Table [S2](#SM1){ref-type="supplementary-material"}). This suggests that the five colistin-resistant strains were truly hypervirulent and hypervirulence of *K. pneumoniae* is not always associated with the hypermucoviscous phenotype.

![Survival of *G. mellonella* after infection by the colistin-resistant hypervirulent strains. The effect of 1 × 10^6^ CFU/ml of each hvKP isolate on survival of *G. mellonella* is shown, while those of other inoculums are shown in Supplementary Table [S2](#SM1){ref-type="supplementary-material"}. KP10 and KP13F4 were two *bla*~KPC-2~-carrying carbapenem-resistant *K. pneumoniae* clinical isolates of ST11 and were used as the control.](fmicb-09-02568-g002){#F2}

Only one (strain KP775) of the five strains carried a known plasmid-borne colistin resistance gene, *mcr-1* (Table [2](#T2){ref-type="table"}). Chromosomal mutations in genes encoding PhoPQ, PmrAB, and CrrAB two-component systems and mutations or insertions in *mgrB*, which encodes a small transmembrane protein can confer resistance to colistin in *K. pneumoniae* ([@B24]). These genes were examined in the five strains to identify mutations and insertions. Three strains had the known colistin-resistant D150G substitution in PhoQ ([@B24]) including the one carrying *mcr-1*, while no known colistin-resistant mutations and insertions were present in the remaining two strains, KP925 and KP209. However, both KP925 and KP209 had a C1031T mutation of *pmrB*, which encodes a P344L substitution (*pmrB*^P344L^). It is unknown whether the P344L substitution of PmrB could mediate colistin resistance. Cloning of *pmrB*^P344L^ into a colistin-susceptible strain and cloning of *pmrB*^wild^ from the colistin-susceptible strain into both KP925 and KP209 were successful and *pmrB*^wild^ or *pmrB*^P344L^ was indeed expressed in the corresponding transformants. However, the introduction of *pmrB*^wild^ or *pmrB*^P344L^ did not alter MICs of colistin against the corresponding strains (Table [3](#T3){ref-type="table"}).

###### 

MICs colistin against of KP9G2, KP925, and KP209 and their transformants.

  Strain                         *pmrB* type on chromosome   *pmrB* type on pBC SK   Colistin MIC (μg/ml)
  ------------------------------ --------------------------- ----------------------- ----------------------
  9G2                            Wild                                                1
  9G2 (pBC SK-*pmrB*^P344L^)     Wild                        P344L                   1
  KP925                          P344L                                               8
  KP925 (pBC SK)                 P344L                                               8
  KP925 (pBC SK-*pmrB*^wild^)    P344L                       Wild                    8
  KP925 (pBC SK-*pmrB*^P344L^)   P344L                       P344L                   8
  KP209                          P344L                                               8
  KP209 (pBC SK)                 P344L                                               8
  KP209 (pBC SK- *pmrB*^wild^)   P344L                       Wild                    8
  KP209 (pBC SK-*pmrB*^P344L^)   P344L                       P344L                   8

All five strains were susceptible to amikacin, gentamicin, ciprofloxacin, piperacillin-tazobactam, imipenem and tigecycline. Only one strain, KP775, was resistant to ceftriaxone and sulfamethoxazole-trimethoprim. Consistent with its resistance phenotype, strain KP775 had the extended-spectrum β-lactamase gene *bla*~CTX-M-14~, sulphonamide-resistance genes *sul1, sul2* and *sul3*, and trimethoprim-resistance genes *dfrA1* and *dfrA12*.

Discussion
==========

*Galleria mellonella* is a well-established model for testing bacterial virulence ([@B26]). Our virulence assays clearly suggest that the five colistin-resistant hvKP strains in this study displayed a hypervirulent phenotype. The combination of hypervirulence and carbapenem resistance has been increasingly reported recently ([@B2]; [@B9]; [@B10]; [@B34]; [@B36]). However, reports on the combination of hypervirulence and colistin resistance remain scarce. Nonetheless, a hvKP strain carrying *mcr-1* has been described ([@B13]) and colistin resistance can be developed *in vitro* from colistin-susceptible hvKP strains ([@B7]). Recent studies have also found that in addition to the well known K1 (mainly associated with ST23) and K2 (associated with a few STs such as ST14, ST25, ST65, ST86, ST110, ST373, ST374, ST375, ST380, ST434, and ST679) ([@B32]) types, a few other types such as ST36:K62 ([@B10]), ST412:K57 ([@B19]) and ST420:K20 ([@B29]) can also become hypervirulent. In this study, we found hvKP strains of a new type, ST660/K16, which expands the spectrum of hvKP. Among the four sequence types identified in the present study, ST23 is a common type associated with liver abscess in East Asia ([@B18]; [@B20]; [@B16]), while the remaining three STs (ST412, ST660, and ST700) remain uncommon in clinical infections. ST412 and ST660 shared five identical alleles out of the seven used for MLST and appear to belonged to the clonal group 37 ([@B19]), which contains ST37, a relatively common type associated with healthcare associated infections ([@B15]; [@B17]). Strains of ST412 have been found causing bloodstream infections in China ([@B19]; [@B21]) and several ST412 strains ave been recovered from throat and nasal swabs (the Klebsiella PasteurMLST database^[5](#fn05){ref-type="fn"}^). There are two ST660 strains in the database^[5](#fn05){ref-type="fn"}^, which have been recovered from sputum in China and human blood in Vietnam, respectively. ST700 is very different from ST23, ST412, and ST660 with one or two identical alleles and is also not closely related to any common types associated with clinical infections such as clonal group 258. There is only one ST700 strain (from human urine in China in the database^[5](#fn05){ref-type="fn"}^.

The five patients received a carbapenem (imipenem or panipenem) or piperacillin-tazobactam for treatment (Table [1](#T1){ref-type="table"}). Four patients recovered, while one who had pancreatic cancer died. Although all strains were susceptible to piperacillin-tazobactam and carbapenems and most patients had favorable outcomes, it seems inevitable that hvKP strains with resistance to both carbapenems and colistin will soon emerge, in light of the presence of plasmid-borne colistin resistance, carbapenem resistance and hypervirulent factors.

A previous study has found that colistin-resistant mutants of ST23:K1 *K. pneumoniae* have reduced virulence compared to their colistin-susceptible progenitors with one mutation even losing the hypermucoviscous phenotype ([@B7]). These colistin-resistant mutants have been obtained via *in vitro* passages and selection with colistin ([@B7]). By contrast, the strains in the present study do not have colistin-susceptible progenitors to compare, as they were wild strains. Nonetheless, one ST23:K1 strain (KP925) in the present study was not hypermucoviscous, which is consistent with the findings of the previous study ([@B7]). On the other hand, both ST23:K1 still exhibited hypervirulence in the *G. mellonella* model. Therefore, we are unable to confirm the association with colistin resistance and reduced virulence in the previous study ([@B7]) due to the absence of the colistin-susceptible progenitors as control but such an association warrants further investigations.

Our study suggests that the P344L substitution of PmrB does not mediate colistin resistance in *K. pneumoniae*. The P344L substitution of PmrB has been seen STs other than ST23 ([@B25]) and not all ST23 strains have the substitution ([@B7]). Therefore, the colistin resistance mechanism in strains KP209 and KP925 remains undetermined. In addition to mutations or insertions in genes encoding PhoPQ, PmrAB, CrrAB, and MgrB, other mechanisms such as capsule have been suggested to be associated with colistin resistance in this species ([@B11]). The association of capsule and colistin resistance in strains KP209 and KP925 therefore warrants further studies.

Conclusion
==========

In conclusion, we identified five colistin-resistant hvKP strains of different clonal backgrounds. Surveillance of colistin-resistant hvKP strains is urgently required to generate essential information for preventing their spread.
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